Sildenafil Citrate Tablet
Product Images NDC 72789-404

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 72789-404). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789404 Label (72789404)

SILDENAFIL USP 25 MG tablet label from PD-Rx Pharmaceuticals, Inc. This prescription drug label indicates a package containing 30 tablets. The label includes dosage strength (25 mg), usage instructions placeholders, reorder and lot information, expiration date (10/2025), and a QR code. The label is designed with green and black text on a white background, including a warning to keep out of reach of children and storage instructions to see the package insert.*

FDA Label Image

Sildenafil-citrate-figure-1 (Sildenafil Citrate Figure 1)

A line graph showing the mean change from baseline in sitting systolic blood pressure over 24 hours in healthy volunteers after dosing. The x-axis represents time post dose in hours, and the y-axis shows change in systolic blood pressure in mmHg. Two lines compare results for Sildenafil Citrate 100mg and placebo.*

FDA Label Image

Sildenafil-citrate-figure-2 (Sildenafil Citrate Figure 2)

A line graph titled 'Mean Standing Systolic Blood Pressure Change from Baseline' showing changes over time postdose (0 to 8 hours). Two lines compare Doxazosin + Placebo (blue) versus Doxazosin + Sildenafil 25 mg (black) in millimeters of mercury (mmHg). The graph depicts blood pressure change variations between the two groups across the time points.*

FDA Label Image

Sildenafil-citrate-figure-3 (Sildenafil Citrate Figure 3)

A line graph showing mean standing systolic blood pressure change from baseline over time postdose (hours). It compares two groups: Doxazosin + Placebo and Doxazosin + Sildenafil 50 mg, with changes in systolic blood pressure (mmHg) plotted on the y-axis and time (hours) on the x-axis. The Doxazosin + Placebo group is represented by a blue line with circles, and the Doxazosin + Sildenafil 50 mg group by a black line with diamonds.*

FDA Label Image

Sildenafil-citrate-figure-4 (Sildenafil Citrate Figure 4)

A line graph showing mean standing systolic blood pressure change from baseline over 8 hours after dosing. Two lines compare the effects of doxazosin with sildenafil 100 mg and doxazosin with placebo, plotted against time on the x-axis (hours) and blood pressure change in mmHg on the y-axis.*

FDA Label Image

Sildenafil-citrate-figure-5 (Sildenafil Citrate Figure 5)

A line graph showing mean sildenafil plasma concentrations over time in healthy male volunteers following treatment with either sildenafil or a commercial tablet. The y-axis represents plasma concentration in ng/mL, and the x-axis shows time post dose in hours, illustrating the pharmacokinetic profile of sildenafil.*

FDA Label Image

Sildenafil-citrate-figure-6 (Sildenafil Citrate Figure 6)

Two bar charts comparing the effect of sildenafil citrate versus placebo on the maintenance of erection by baseline score. The vertical axis shows the percentage of patients at the endpoint, and the horizontal axis shows baseline scores ranging from 0 to 5. Bars represent different scores (0 to 5) at endpoint for each baseline score category.*

FDA Label Image

Sildenafil-citrate-figure-7 (Sildenafil Citrate Figure 7)

A bar chart comparing the percentage of patients reporting improvement among different treatment groups. The groups include Placebo, Sildenafil citrate 25 mg, Sildenafil citrate 50 mg, and Sildenafil citrate 100 mg. The vertical axis represents the percentage reporting improvement, ranging from 0% to 100%, with corresponding values of 24%, 63%, 74%, and 82% respectively for each group on the horizontal axis.*

FDA Label Image

Sildenafil-citrate-structure (Sildenafil Citrate Structure)

Chemical structure of Sildenafil Citrate, showing its molecular configuration with labeled atoms and bonds consistent with the active ingredient Sildenafil Citrate in the drug product.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.